-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $110

Benzinga·07/13/2026 14:15:34
语音播报
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $100 to $110.